Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Blood DNA methylation and breast cancer risk: a prospective nested case-control study.

EBioMedicine·2026

Same author

A long-term image-derived AI-based risk model for primary prevention of breast cancer in individuals at high risk.

Science translational medicine·2026

Same author

The impact of community-acquired critical sepsis on long-term mortality and morbidity-a nationwide cohort study.

Scientific reports·2026

Same author

Germline Pathogenic Variants in Breast Cancer-Predisposing Genes Among Early-Onset Female and Male Breast Cancer in Ethiopia.

JCO global oncology·2026

Same author

Endoxifen for mammographic density reduction-results from the KARISMA endoxifen trial.

Journal of the National Cancer Institute·2026

Same author

Initiation of High-Potency Benzodiazepine Prescriptions Among Survivors of Severe Trauma.

Acta anaesthesiologica Scandinavica·2026

Same journal

Durable Response to Sotorasib in KRAS G12C-Mutant Intrahepatic Cholangiocarcinoma: A Case Report.

The oncologist·2026

Same journal

The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective Study.

The oncologist·2026

Same journal

Prevalence, treatment and survival of Malignant Peripheral Nerve Sheath Tumor in the Danish neurofibromatosis type 1 population.

The oncologist·2026

Same journal

Molecular Tumor Board-Guided Osimertinib Therapy in EGFR L858R/Q701L-Mutant Lung Adenocarcinoma Supported by Functional Validation.

The oncologist·2026

Same journal

Phase 2 Dose Expansion Trial of OBI-3424, a DNA-Alkylating Prodrug, in Patients with Advanced Solid Tumors Expressing AKR1C3.

The oncologist·2026

Same journal

Divergent Biology and Outcomes of Somatic Transformations in Germ Cell Tumors.

The oncologist·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 22, 2025

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

Time to Mammographic Density Decrease After Exposure to Tamoxifen.

Magnus Bäcklund¹, Mikael Eriksson¹, Mattias Hammarström¹

¹Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

|May 23, 2022

Summary

This summary is machine-generated.

Tamoxifen therapy significantly reduces mammographic density within 3 months, indicating treatment effectiveness. Dosage did not impact density changes, side effects, or adherence in this study.

Keywords:

breast cancer breast density clinical trial primary prevention tamoxifen

More Related Videos

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Published on: October 16, 2010

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Related Experiment Videos

Last Updated: Sep 22, 2025

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Published on: October 16, 2010

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Area of Science:

Oncology
Radiology
Pharmacology

Background:

Mammographic density is a validated biomarker for predicting response to tamoxifen therapy.
Understanding the temporal dynamics of density changes is crucial for assessing treatment efficacy.

Purpose of the Study:

To determine the time course of tamoxifen-induced mammographic density reduction.
To evaluate the impact of tamoxifen dosage on density changes, side effects, and patient adherence.

Main Methods:

A randomized study involving 42 women receiving daily oral tamoxifen (10 or 20 mg).
Mammograms were acquired at baseline and at 3, 6, and 9 months.
Mammographic density was quantified using the automated STRATUS tool; adverse events were tracked via a FACT-ES based questionnaire.

Main Results:

A statistically significant decrease in mammographic density was observed by 3 months of tamoxifen treatment.
No significant differences in density change, adverse events, or adherence were noted between the 10 mg and 20 mg tamoxifen groups.
21% of participants discontinued therapy due to adverse events.

Conclusions:

Tamoxifen effectively reduces mammographic density, with changes evident as early as 3 months.
Tamoxifen dosage does not appear to influence treatment response, tolerability, or adherence.
Further research with larger cohorts is warranted to validate these findings.